Back

Red cell distribution width and association with all-cause mortality: an easy-to-use and readily available biomarker in patients with atrial fibrillation and chronic heart failure

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and heart failure (1) Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marco Vitolo

Modena Polyclinic Modena University Hospital, Modena (Italy)

4 More presentations in this session

Presentation thumbnail
Management of new-onset atrial fibrillation in the intensive care unit: where do we stand?
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Occult heart failure with preserved ejection fraction in atrial fibrillation: changes in HFA-PEFF-score and left atrial strain after cardioversion
Doctor R. Kumari (Bishkek, KG)
Abstract Slides Video
Presentation thumbnail
Longer postoperative atrial fibrillation correlates with higher recurrence of atrial fibrillation in patients with heart failure with reduced ejection fraction
Associate Professor M. Klinceva (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Arrhythmia-induced cardiomyopathy: clinical and echocardiographic characteristics compared to idiopathic dilated cardiomyopathy
Doctor A. Minghini (Genova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and heart failure (1)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Elevated red cell distribution width (RDW) and adverse outcomes in patients with atrial fibrillation: new insights from a contemporary prospective study
thumbnail
Congress Presentation
Higher red blood cell distribution width is associated with worse outcomes in patients with chronic heart failure
thumbnail
Congress Presentation
Red blood cell distribution width is a useful biomarker to predict prognosis in patients admitted for acute heart failure and with a preserved left ventricular ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources